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Abstract 
 
 
 
Felemban, Dalal. M.S. Department of Biological Sciences, Wright State 
University, 2016. The Effects of Cold and Freezing Temperatures on The 
Blood Brain Barrier and Aquaporin 1, 4, and 9 Expression in Cope’s Gray 
Treefrog, Hyla chrysoscelis. 
 
 
 In sub-freezing temperatures, cerebrospinal fluid (CSF) and blood 
plasma within the brain of freeze-tolerant gray treefrogs, Hyla chrysoscelis, 
are likely to freeze.  We hypothesized that this would challenge blood-brain 
barrier (BBB) integrity and volume regulation for cells in the brain.  Our 
first hypothesis, tested as cerebral Evans blue permeability, was not 
supported; BBB integrity appeared uncompromised by cold.  Our second 
hypothesis, tested as changing expression of aquaporin (AQP) proteins, was 
partially supported.  Whole-brain expression (Western blot) of AQP1 and 
AQP4 were unchanged by cold conditions, but AQP9 expression increased 
in thawed animals. AQP1 was found (immunohistochemistry) in ependymal 
cells, endothelial cells, neurons, and astrocytes, AQP4 and AQP9 in neurons 
and astrocytes. Cell localizations of AQPs were not changed by thermal 
conditions, but cold conditions did enhance immunofluorescence intensity.  
 iv 
The brain of gray treefrogs is protected from damage during freezing.  
Changing expression of AQPs may protect cells during cold-induced 
osmotic challenges.  
  
 v 
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1.0 Introduction 
1.1 Freeze tolerance  
 Surviving in cold climates forces an organism to face many 
environmental challenges, including reduced access to food, shorter summer 
periods, and subfreezing temperatures in the winter season. Many small 
vertebrate species hibernate under water or under ground to avoid freezing 
temperatures. However, some species hibernate in damp or less isolated 
areas and are not protected from freezing. These animals must find a way to 
deal with several internal physiological challenges that result from freezing 
temperatures. For instance, metabolism decreases overall and is limited for 
selected functions. Oxidative stress may result from the unstable blood flow 
that occurs with repetitive freezing and thawing. Further, physical damage 
may occur due to ice formation, particularly if ice forms inside the cells. 
“Freeze tolerance” requires a combination of adaptations to protect an 
organism against the harmful effects of freezing (Story and Story, 1992, 
Costanzo et al., 1995; Story and Story, 1996). 
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 One important component of freeze tolerance is to minimize physical 
damage by limiting ice formation to the extracellular fluids. As the 
extracellular fluids freeze, pure water becomes solidified as ice, thereby 
increasing the concentration of the extracellular solutes, creating a hyper-
osmotic environment that draws water from the cell. This causes a reduction 
in intracellular water and volume, shrinking the cell.  On the other hand, 
once the ice thaws, the melted water dilutes the extracellular solutes, 
potentially creating a hypo-osmotic extracellular environment resulting in 
water diffusing to the inside of the cell. This causes the cell to swell. This is 
physiologically stressful with repeated cycles of shrinking and swelling due 
to freezing and thawing, respectively. Therefore, animals that would be 
repeatedly exposed to freezing temperatures must have physiological 
adaptations, such as a mechanism to control water flux, that allow them to be 
freeze tolerant in subfreezing environments (Costanzo et al., 1992; Storey 
and Storey 2004; and Storey and Storey 2013). 
 There are a number of strategies that an organism may be able to use 
to survive the osmotic challenges presented by sub-freezing temperatures. 
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One of these is to accumulate cryoprotective solutes.  Cope’s gray treefrog 
(Hyla chrysoscelis) is one of the identified species of freeze tolerant frogs. 
These frogs are able to survive freezing for weeks and recover rapidly.  
During the cold, gray treefrogs accumulate glycerol as a cryoprotectant, and 
at the time of freezing they liberate glucose. These solutes are thought to be 
derived from glycogen in the liver and they accumulate in the blood and are 
distributed to different organs within body (Storey and Storey, 1984). 
Glucose or glycerol work as cryoprotectants to prevent cell damage during 
freezing (Krane and Goldstein, 2007).  Additionally, these frogs redistribute 
body fluids in order to protect cells from freeze damage (Lee et al., 1992).   
 Another strategy involves the expression of aquaporins. Aquaporins 
are protein channels in the plasma membrane that serve to facilitate and 
control the passage of water and, in some cases, small organic solutes. 
Aquaporin-facilitated water flux has been a mechanism suggested to be used 
by bacteria that allow them to survive rapid freezing. The critical role of 
aquaporins in controlling cell volume and responding to osmotic changes 
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may have resulted in the selective pressure that caused these proteins to be 
retained and diversify with evolution (Tanghe et al., 2006). 
 When gray treefrogs freeze, the bulk liquids in the brain, including the 
blood plasma and the cerebrospinal fluid (CSF), are likely to freeze. The ice 
formation in extracellular space creates significant challenges including cell 
damage or cell volume changes. Furthermore, the blood-brain barrier (BBB) 
could be compromised as well by glucose released at the time of freezing or 
by physical damages. How do neural tissues survive these stresses? 
 
1.2 Blood-Brain Barrier 
 The concept of the blood-brain barrier (BBB) was established more 
than 100 years ago as the vascular barrier between the circulating blood and 
the central nervous system (CNS). In the 1880s, Paul Ehrlich observed that 
certain dyes injected into the vascular system were able to stain all organs 
except the brain and spinal cord. At the time, Ehrlich suggested that these 
findings were due to the dyes’ lack of affinity for the nervous system. 
However, an associate of Ehrlich, Edwin E. Goldman, noted that the same 
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dyes were able to successfully stain nervous tissue, but not any other tissue, 
when injected directly into the cerebrospinal fluid. This indicated that there 
was some form of barrier that was preventing access of the dyes to the CNS 
from the vascular system. Moreover, other studies have demonstrated that 
certain neurotoxic agents are only capable of affecting the brain when 
injected directly into the brain. Taken together, these observations suggested 
that there is a barrier that separates the brain from the rest of the body, 
including the vasculature. Indeed, the BBB serves as this gate and controls 
the molecules transferred between the CNS and the blood (Engelhardt, 2003; 
Engelhardt and Sorokin, 2009). 
 The small blood vessels of the brain have unique characteristics that 
form the BBB. The structure of the BBB is composed of three types of cells: 
endothelial cells, astrocytes (specifically the end feet) and pericytes (Fig. 1). 
The adjacent endothelial cells form complex tight junctions (TJs) that 
selectively prevent most of the molecules in the blood circulation from 
crossing the vessel wall into the brain tissue (Fig. 1). Further, the pericytes 
play a key role in angiogenesis, structural integrity and differentiation of the 
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vessel, as well as formation of the endothelial TJs. Astrocytes contribute to 
the BBB particularly through their end feet structures (Loreto and Reggio, 
2010). Each of these three cell types are believed to be significant for the 
normal function and stability of the BBB (Ballabh et al., 2004).  
 
 Fig 1: The structure and function of the Blood–Brain Barrier (BBB). 
(A) Brain barriers. (B) BBB structure. (C) BBB Transport. (D) Tight 
junctions complex. (Adapted from Aday et al, 2016) 
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1.3 BBB Functions in Normal and Pathological Brain conditions 
 Under normal circumstances, the BBB regulates the homeostatic 
environment of the mammalian brain and spinal cord by allowing only 
specific and limited small solutes to cross the CNS. Small lipophilic 
molecules, such as oxygen and carbon dioxide, are able to cross the plasma 
membrane based on their concentration gradient. Other molecules, for 
instance glucose and amino acids, need specific transporters to enter the 
brain; certain macromolecules like insulin, leptin, and transferrin cross the 
CNS through receptor-mediated endocytosis (Fig1) (Ballabh et al., 2004, 
Pardrige, 1999, and Negy et al., 1987).  
 This strict BBB barrier can be altered by CNS injuries such as 
ischemia, hemorrhage, or traumatic injury.  For example, cerebral ischemia 
caused by a stroke can result in increased permeability of the BBB, leading 
to the influx of fluid into the brain (i.e., edema) (Kim et al., 2009).  
Lossinskyan and Shivers (2004) described that animals exposed to factors 
such as injury, cold lesion, and inflammatory conditions showed alterations 
in the normal structure and function of BBB. Animals such as mice, cats, 
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and gerbils that were subjected to cold lesion injury displayed BBB 
disruption revealed by injection with protein tracers (Lossinsky and Shivers, 
2004). Additionally, inflammatory conditions of the BBB, including 
exposure to toxic or hypertonic compounds, were shown to increase the 
permeability of the BBB (Lossinsky and Shivers, 2004). Shivers (1978) 
showed through tracer analyses that hyperglycemia could increase 
permeability, thereby disrupting the BBB in the lizard brain. 
 
 Kim et al. (2009) assessed the BBB disruption in mouse brains during 
a study to evaluate the effectiveness of the drug agmatine for brain edema. 
They observed that agmatine could attenuate edema by reducing BBB 
disruption, specifically by down-regulating expression of specific proteins 
involved in regulating fluid transport across blood vessels. These proteins 
known as aquaporins (AQP), belong to a family of molecules responsible for 
transporting water and other solutes (i.e., glycerol) across cells in the BBB, 
as well as many other cell types.  
1.4 Aquaporins  
  AQP proteins form a family of membrane proteins that confer 
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permeability to water and, in many cases, other small molecules.  
Aquaporins are expressed in the cell membrane as tetramers. The structure 
of each monomer includes six transmembrane alpha-helices with five 
interhelical loop regions (A-E). The amino and carboxyl termini lay on the 
cytoplasmic side of the membrane. The two halves of each aquaporin 
monomer fold back on each other to form a pore that provides the 
permeability pathway.  The four monomers together form an additional pore 
in the tetramer that may add to the permeability properties (Gonen & Wals, 
2006; Benga, 2009; Buffoli, 2010).  
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Fig 2: The basic structure of AQPs. The monomer includes six 
transmembrane alpha-helices with five interhelical loop regions (A-E). The 
amino and carboxyl termini lay on the cytoplasmic side of the membrane. 
The two halves of each aquaporin monomer fold back on each other to form 
a pore. (Picture adapted from Nagelhus and Ottersen, 2013) 
 
 Different organisms express different numbers of aquaporins.  
Humans express 13 proteins, designated as AQP0-12. The different peptide 
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sequences in these AQPs create different type pore sizes. Therefore, AQPs 
are classified into three sub-groups according to their permeability. The first 
sub-group is Aquaporins (AQP0, 1, 2, 4, 5, 6 and 8) that only allow water to 
pass. The aquaglyceroporin sub group including AQP3, 7, 9, and 10 is 
permeable to water and also to other molecules such as glycerol and urea. 
The last sub-group is the super-aquaporins (AQP11, 12) that are found in the 
cytoplasm and might have roles in water intracellular transport (Buffoli, 
2010, Badaut et al., 2014). Amphibians express homologs of these human 
aquaporins. 
  AQP1, 3, 4, 5, 6, 8, 9, and 12 were reported in brain tissues (Badut et 
al., 2014). AQP1, 4, and 9 appear to be the most significant AQPs in brain. 
The distribution of these three AQPs has been identified in normal and 
pathogenic brain in many studies.  
 Under normal conditions in mammalian brain, AQP1 is found mainly 
at the apical surface of the choroid plexus epithelium and, to a lesser extent, 
in the basolateral membrane of the endothelium, where it plays an important 
role in cerebrospinal fluid secretion (Loreto and Reggio, 2010). 
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Furthermore, AQP1 was localized in dorsal horn of spinal cord, and the 
trigeminal sensory ganglia, which indicate that it may play role in 
nociception (Badaut et al., 2014). In contrast, under pathological conditions 
AQP1 is expressed in other tissues sites where water transport is 
upregulated, such as in cerebral vessel endothelia to clear edema water from 
the brain (Loreto and Reggio, 2010). Also, AQP1 was localized in some 
neuronal processes in brain septum are increased after brain injuries. AQP1 
was found in astrocytes in non-human primate (Badaut et al., 2014).  
 AQP4 is the most investigated AQP in the brain due to its diverse and 
significant roles. AQP4 is the predominant AQP in the CNS and is a crucial 
component of the BBB, where it is critical for water homeostasis within the 
brain (Loreto and Reggio, 2010, Badaut et al., 2014).  It was found in 
astrocyte end feet that connected with cerebral vascular endothelia, 
especially concentrated in cerebral cortex, where it plays important roles in 
water mobility in brain. Under some pathological conditions AQP4 
contributes to increasing edema, but at other times it has a role to decrease 
edema (Badaut et al., 2014). In addition to water homeostasis function, 
AQP4 may play other physiological roles associated with its distribution in 
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other brain tissues such as hippocampus, corpus callosum, cerebellum, 
magnocellular nuclei of hypothalamus, and brain stem.  For example, studies 
of AQP4 knockout mice AQP4 -/- indicate that AQP4 plays a role in cell 
adhesion and might influence astrocyte characteristics.   
AQP9 is an aquaglyceroporin that transport water and other molecules 
such as glycerol, urea, and monocarboxylate. AQP9 was reported in 
astrocytes, endothelial cell of sub-pial vessels, and catecholaminergic 
neurons. It was found in two forms: 26KDa in the inner membrane of 
mitochondria and 30KDa in cell membrane. AQP9 is believed to play role in 
neuronal and astrocyte energy by facilitating glycerol and using glycerol as 
energetic substrate. (Badaut et al., 2014).  
 These data suggest that AQP expression contributes importantly to the 
function of the BBB, and that AQPs can be key factors to reduce or 
compensate for BBB disruption in CNS injuries. 
   
1.6 Study Goals and Hypothesis 
 A variety of experimental and pathological conditions can lead to 
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damage or changing properties of the BBB in rodents and other animals. We 
hypothesize that cold and, especially, freezing temperatures will break the 
BBB and increase the AQPs expression. The Cope’s gray treefrog Hyla 
chrysoscelis serves as a natural model for such research as it can withstand 
the extreme cold or freezing temperatures and survive/recover. During 
acclimation to cold and freezing temperatures, the circulation and blood flow 
decreases, which may, to an extent, mimic ischemia conditions. Moreover, 
freezing states cause an increase in osmolality outside cells including the 
endothelial cells of BBB due to ice formation. In turn, this causes the cells to 
shrink, which may impact BBB permeability by potentially disrupting TJs. 
Additionally, AQPs expression may alter in order to control water flux 
during the repeating cycle of freezing and thawing. To test my hypothesis, I 
propose the following two specific aims to assess whether the stability of the 
BBB is compromised under cold or freezing conditions and whether AQP 
expression is altered. 
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1.7 Specific Aims 
Aim 1:  I assessed BBB integrity in Hyla chrysoscelis using Evans blue 
tracer analysis in animals acclimated to 5˚C (cold-acclimation) and animals 
exposed to -2.5˚C (frozen and thawed) in comparison with animals held at 
ambient laboratory conditions (~22˚C).  
 
Aim 2:  I evaluated the expression of AQP1, 4, and 9 protein in brains of 
Hyla chrysoscelis acclimated to 5˚C only and animals exposed to -2.5˚C, in 
comparison to animals held at ambient laboratory conditions (~22˚C).  
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2.0 Material and methods: 
 
2.1 Animal collecting 
 Cope’s gray treefrogs, Hyla chrysoscelis, were collected from 
breeding sites in Greene County, Ohio, USA. Animals were transferred to 
the laboratory animal housing facility at Wright State University and housed 
individually or in pairs using standard housing conditions (60 cm × 30 cm × 
30 cm cages with vented tops). The habitat’s photoperiod was set to 12 h:12 
h light/dark, and the temperature was set to a constant 22 °C. Animals were 
allowed free access to water and were fed crickets ad libitum twice per 
week. 
 All animal experiments were performed in accordance with and 
approved by Wright State University’s Institutional Animal Care and Use 
Committee. 
 
2.2 Cold and freezing acclimation 
Frogs were divided into four groups representing different 
physiological conditions (warm acclimated, cold acclimated, frozen, 
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thawed/post-freeze recovery). One group was held in standard housing at 
22˚C (warm acclimated, control group). The remaining animals were 
transferred to a cold room to start the cold acclimation process.  
Temperatures were adjusted gradually from 20˚C to 5˚C over an eight 
weeks span. Animals had access to water and were fed crickets until they 
naturally stopped feeding at ~10˚C. Cold-acclimated animals were 
maintained at 5˚C, and some these cold-acclimated animals were then frozen 
or frozen and subsequently thawed. 
 The freezing process took one week where the temperature decreased 
~1˚C/day (2, 1, 0, -1, -2, -2.5˚C). When the temperature reached -2.5˚C, a 
piece of ice was touched to a cold moistened gauze pad on which the frog 
rests, and the frog quickly became frozen. The frozen group was killed after 
24 hours at -2.5˚C, and the thawed group was returned to 5˚C for 24 h to 
recover before being killed to evaluate the possible damages from freezing 
(Fig2).  
 Brains were collected from each condition for analysis by histology, 
immunofluorescence, and immunoblotting. 
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2.3 Evaluation of BBB disruption  
 Blood-Brain Barrier (BBB) disruptions were assessed using Evans 
Blue (EB) as a nontoxic high-molecular weight vascular permeability 
marker. It provides a rapid and reliable assessment of global BBB 
permeability. EB binds to albumin in the blood and it is an indicator for 
BBB disruption if it is observed in the brain (Kaya and Ahishali, 2011).  
 A 1% EB solution was prepared by dissolving EB (Sigma, St. Louis, 
MO) in a physiological saline solution then sterile filtering. The EB solution 
was injected intraperitoneally (4 µl/g). 
 Belayev et al. (1996) examined the injection of EB over various time 
courses (3-4-5-26-50 h) 2-3-24-48 h after the onset of middle cerebral artery 
occlusion. The authors described no visible areas of EB extravasation, 
except in the stroma of the choroid plexus in the brains of the 2-3 h and 24-
26 h recirculation groups.  Therefore, frogs were injected with 1% EB in 
saline and that was allowed to circulate for 24 h. Having three different 
temperature conditions, however, may pose an issue for EB circulation. 
Harri and Talo (1974) demonstrated the impact of temperature on the 
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response of an isolated frog's heart. The authors showed that the heartbeats 
decreased with lower temperatures, implying that the heartbeat will be less 
frequent and blood flow will likely be diminished with lower temperatures 
during cold acclimation and the freezing process. Therefore, EB was 
allowed 24 h to circulate in order to account for the potential of a slower 
blood flow. For the control groups, frogs were injected with 1% EB in saline 
for 4 h (Fig3) (Belayev et al., 1996; Kim et al., 2010; Kaya & Ahishali, 
2011; Manaenko et al., 2011). 
a) Frogs acclimated to ~22˚C were injected with 1% EB in saline 4 h 
prior to euthanasia. 
b) Frogs acclimated at 5˚C were injected with 1% EB in saline 24 h 
prior to euthanasia. 
 c) Frogs in frozen state were injected at -2˚C with 1% EB in saline to 
allow EB to circulate 24 h prior to freezing.  
d) Frogs in thawed state were injected at -2˚C with 1% EB in saline to 
allow EB to circulate 24 h prior to freezing, then frogs were returned 
to 5˚C to thaw for 24 h (Fig2). 
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Fig 3: Cold and freezing acclimation and Evans Blue injections. a) 
Frogs acclimated to ~22˚C were injected with 1% EB in saline 4 h 
prior to euthanasia. b) Frogs acclimated at 5˚C were injected with 1% 
EB in saline 24 h prior to euthanasia. c) Frogs in frozen state were 
injected at -2˚C with 1% EB in saline to allow EB to circulate 24 h 
prior to freezing. d) Frogs in thawed state were injected at -2˚C with 
1% EB in saline to allow EB to circulate 24 h prior to freezing, then 
frogs were returned to 5˚C to thaw for 24 h. 
 
3 A 
3 C 
3 B 
3 D 
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2.4 Protein isolation and Western Blotting 
 The relative quantitative expression of AQP-1, -4, and -9 in the brain 
was estimated by immunoblotting. Immunoblotting was performed using 
rabbit anti-AQP polyclonal antibodies and a mouse anti-beta actin 
monoclonal antibody (Abcam, Cambridge, MA) for protein loading control 
purposes. Frogs were euthanized under anesthesia and the whole brain was 
quickly removed, frozen in liquid nitrogen, and stored at −80 °C. Tissues 
were homogenized in protein lysis buffer containing protease inhibitor 
cocktail, incubated with 1% Triton-X100 and pipet mixed on ice every 10 
minutes for 30 minutes, and centrifuged 10 min at 10,000×g (Pandey et al., 
2010). Total protein was quantified using a BCA Protein Assay 
(ThermoFisher, Waltham, MA). 20 μg of total protein were added to loading 
buffer and separated on a 12% SDS–polyacrylamide electrophoresis gel at 
150V for 1.5 h along with prestained protein ladder. Proteins were 
transferred to polyvinylidene difluoride (PVDF) membrane, blocked with 
5% nonfat dry milk in phosphate buffered saline with 0.5% Tween-20 
(PBST), and then incubated with primary antibody in 2.5% nonfat dry milk 
 22 
in PBST. The membranes were then treated with Donkey anti-rabbit 
secondary antibody conjugated with HRP prepared in 2.5% milk in PBST. 
Protein bands on blots were detected using enhanced chemiluminescence 
(ThermoFisher, Waltham, MA) and imaged with a Fujifilm LAS-3000 
system. Specificity of binding was tested by incubating primary antibody 
with a five-fold excess by mass of antigen peptide for 1 h at room 
temperature prior to application to the membrane (Pandey et al., 2010).  
For HC-1 and HC-9, we used autospecific antibodies directed against 
the 16 amino acid peptide sequences at the C-terminal end of HC-1 or CH-9, 
respectively.  For AQP4 we lacked an autospecific antibody and so we 
applied an antibody directed against mouse AQP4. Out of 17 amino acids 
against which that antibody was directed, 8 are identical in mouse and frog, 
5 are strongly similar (on the Gonnet PAM250 matrix), 3 are weakly similar, 
and 1 had zero similarity (Fig 4). To test the adequacy of this antibody on 
our frog model, we compared the pattern of protein bands in Western blots 
of protein extracted from mouse brain with those from treefrog brain (Fig 
11). 
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Fig4: Clustal alignment of the AQP4 homolog HC-4 and a commercially 
available AQP4 polyclonal antibody (Boster Biological Technology). “*” 
means identical match. “:” means strong similar properties. “.” means 
weakly similar properties. 
 
 
2.5 Histology 
 Brains were dissected from frogs and immediately transferred to 
periodate-lysine-paraformaldehyde (PLP) fixative containing 4% 
paraformaldehyde, 75% mM Lysine, 37.5 mM sodium periodate, and 10 
mM Sodium phosphate dibasic (pH 7.2) (Mclean et al., 1974) at 4°C 
overnight. After that, tissues were rinsed with 50% ethanol and dehydrated 
with an increasing ethanol series (50%, 70%, 95%, and 100%). Then, tissues 
were cleared in xylenes and embedded in paraffin (Humason, 1979). Brain 
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tissues were sectioned using a microtome into 5 µm thick slices (Leica 
RM2255 Rotary Microtome, Leica, Germany).  Coronal sections were taken 
from different regions of the brain (anterior, mid-, and posterior) that where 
close to the lateral, third, and optic ventricles, respectively.  The brain 
regions were identified using frog brain atlas (Fig.5) (Capranica, Llina ́s and 
Precht 1976; and Raucci et al., 2006). Some of these sections were stained 
for routine histology with hematoxylin and eosin (H&E) to determine the 
desired region and to identify cells types (Fig 6&7) (Humason, 1979), and 
photographed with a digital camera attached to a light microscope. Due to 
the limited information about frog neuro-histology, cell types were identified 
in our frog model by comparing with mammalian histology. We identified 
the different cell types based on location of cells, size and shape of cells and 
nuclei (Gartner and Hiatt, 2006). Ependymal cell were identified from the 
columnar to cuboidal cell shape, large oval to round nucleus close to the 
basal membrane, and location surrounding ventricles. Neurons were 
identified from the large cell size with large round nucleus. Astrocytes were 
identified by the smaller cells size, small oval nucleus, and location close to 
blood vessels (Fig 6&7). 
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2.6 Immunostaining  
 AQP localization and distribution in brain tissues were visualized 
using immunofluorescence labeling. 
  Sections serially adjacent to those used for H&E staining were 
labeled with one to three aquaporin primary antibodies and fluorophore-
conjugated secondary antibodies to visualize and compare aquaporin 
expression and localization in brain tissues. For single antibody 
immunolabeling, sections were deparaffinized with xylene and rehydrated 
by a decreasing ethanol series (100%, 95%, 80%, 60%). After that, sections 
were moved to a staining dish containing citrate buffer (10mM Citric Acid, 
0.05% Tween 20, pH 6.0) in a 95-100°C water bath for 30 min to recover 
the epitopes from formalin fixation. Sections were held at room temperature 
for 40 minutes to cool, followed by washing with phosphate buffered saline 
(PBS; 0.02 M sodium monobasic phosphate, 0.08 M sodium dibasic 
phosphate, 150 mM sodium chloride, pH 7.2). Then, sections were 
permeabilized with 0.2% Triton X-100, followed by 1% glycine (pH 8) and 
0.1% sodium borohydride (pH 8) to dilute any the remaining formaldehyde. 
Sections were incubated with 10% blocking serum solution (10% serum, 4% 
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BSA, and 0.05% Tween-20) for 1 h at room temperature to decreased non-
specific binding between primary antibody and specimens, followed by 
primary antibody against AQP 1, 4, or 9 diluted in 1% normal goat serum (1: 
200 dilution) overnight at 4°C. After overnight incubation, sections were 
washed with PBS and labeled with goat anti-rabbit Cy2-conjugated 
secondary antibody diluted in 1% normal goat serum (1: 500 dilution) for 
1.5 h at room temperature. Nuclei were counterstained with DAPI staining. 
Signals were visualized under Olympus FV1000 confocal microscope using 
Olympus FluoView ver.1.7a viewer. All images were taken at a standard 
setting for Cy2 or Cy3 labeled secondary antibodies and DAPI nuclear stain 
and images were digitally enhanced by improving the background to 
fluorescence signal ratio. The expression of AQP1, 4, and 9 in brain tissue 
under different physiological conditions was compared visually by 
comparing the immunofluorescence intensity under the same standard 
setting of the confocal microscope. Based on that visual inspection, 
immunofluorescence was rated in intensity on a scale of (++++, +++, ++, +, 
-), where (++++) represents high intensity or very strong signal, (+++) 
represents strong signal, (++) represents weak signal, (+) represents very low 
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intensity signal, and (-) represents no or minimal apparent signal. To 
determine the specificity of the fluorescence for the anti-aquaporin 
antibodies, each antibody was pre-incubated with 200-fold molar excess of 
their specific peptides at room temperature for 1 h before application to the 
tissues (Pandey et al., 2010).  
 Extra steps were performed for double- or triple-labeling using same 
host primary antibody. After first secondary antibody labeling, sections were 
incubated with 5% normal goat serum for 1 h, followed by PBS washing and 
30 μg goat anti-rabbit fragmented antibodies for 1 h (Fab Fragments For 
Blocking And Double Labeling Of Primary Antibodies From The Same 
Host Species". Jackson ImmunoResearch Inc.. N.p., 2016. Web. 16 Dec. 
2016). 
https://www.jacksonimmuno.com/technical/products/protocols/double-
labeling-same-species-primary/example-c 
 
In addition to labeling with anti-aquaporin antibodies, we also applied 
anti-glial fibrillary acidic protein (GFAP) antibody, a marker for astrocytes 
in mammals (Agilent, Santa Clara, CA), in an effort to confirm identification 
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of astrocytes in immunofluorescence images.  Unfortunately, this effort was 
not successful because GFAP appeared to be expressed not only in 
astrocytes in our frog model, but also by Ependymal cell and neurons (Fig17 
and 20).  
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Fig 5: coronal sections from frog brain. A) Coronal section from the anterior 
brain close to the lateral ventricles. B) Coronal section from the mid brain 
close to the third ventricle. C) Coronal section from the back brain close to 
optic ventricles and aqueduct. ACP, anterior choroid plexus; AQ, 
aqueduct;EN, entopeduncular nucleus; HB, habenula; IN, interpeduncular 
nucleus; LEM, lemniscus; LV, lateral ventricle; MOT, medial optic tract; 
NA, nucleus accumbens; NI, nucleus isthmi; OT, optic tectum; OV, optic 
ventricle; PD, dorsal pallium; PL, lateral pallium; PM, medial pallium; 
PONm, magnocellular preoptic nucleus; POR, preoptic recess; SGC, stratum 
griseum centrale; SGP, stratum griseum periventriculare; SM, medial 
septum; TEGd, dorsal tegmentum; TEL, telencephalon; THd, dorsal 
thalamus; TS, torus semicircularis; III, third ventricle. (Pictures were 
adapted from Raucci et al., 2006). 
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Fig 6: Mouse brain tissue stained with hematoxylin and eosin (H&E) 
illustrating the cell types in mouse brain. (adapted from "Dictionary - 
Normal: Caudate - The Human Protein Atlas". Proteinatlas.org. N.p., 2016. 
Web. 28 Dec. 2016. 
http://www.proteinatlas.org/learn/dictionary/normal/caudate/detail+2/magnif
icat) 
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Fig 7: Hyla chrysoscelis brain tissue stained with hematoxylin and eosin 
(H&E). A) (4x) coronal section from anterior brain showing lateral 
ventricles. B) (4x) coronal section from mid- brain showing third ventricle. 
C) (10x) from mid-brain showing the cell types. 
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Statistics  
 One and two factor analysis of variance (ANOVA; Microsoft Excel) 
was applied to determine the statistical significance of AQP1, 4, and 9 levels 
under different physiological conditions (warm, cold, frozen, and thawed). 
The p-value < 0.05 was considered to be significant. 
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3.0 Results 
3.1 Blood Brain Barrier Integrity  
 To examine the integrity of the BBB under different physiological 
conditions (warm, cold, frozen, and thawed), Evans Blue (EB) was used as 
an indicator for BBB disruptions. Specifically, the BBB would be 
considered disrupted if EB was present in brain. Control animals (warm 
condition) were negative for EB in the brain, as expected. Cold, frozen, and 
thawed brains also showed no evidence of EB in all brain areas, even though 
EB was found throughout the body cavity.  Brains in all conditions presented 
as normal color (white to gray) (Fig 8). 
 
3.2 AQP1, 4, and 9 protein expression 
 
3.2.1 HC-1 expression 
 Immunoblots of HC-1 yielded a pattern of 28 kDa and 43 kDa bands 
from all brain tissues. To confirm antibody specificity, the anti-HC-1 
antibody was incubated with HC-1 peptide (where the peptide would 
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neutralize the antibody) after which the antibody was unable to bind HC-1 in 
the Western blot and the 28 kDa and 43kDa bands were no longer 
visualized, confirming the antibody’s specificity for HC-1 (Fig 9).  
 Protein extractions were treated with N-glycosidase, an enzyme that 
cleaves the n-linked glycan molecule, to test if the higher molecular weight 
band represented glycosylated protein (Hendriks et al., 2004; Lu et al., 2008; 
and Takata et al., 2008). The higher molecular weight band (43 kDa) 
disappeared after treatment with N-glycosidase enzyme, indicating that it did 
represent glycosylated protein (Fig 10).  
 HC-1 protein intensity was consistent under different physiological 
conditions (warm, cold, frozen and thawed), with no statistically significant 
differences between conditions (Fig. 8, p = 0.78).  
 
3.2.2 AQP4 expression 
Since we lacked an AQP4 autospecific antibody, we applied an 
antibody directed against mouse AQP4. We tested the adequacy of this 
antibody on our frog model, by comparing the pattern of protein bands in 
Western blots of protein extracted from mouse brain with those from 
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treefrog brain (Fig 11). Immunoblots of protein extracted from mouse brain 
produced a pattern of five bands (170, 55, 50, 43, and 26 kDa), while the 
same anti-AQP4 antibody, applied in our frog model, produced three bands 
(55, 50, and 43 kDa) that were similar to those observed for mouse brain. 
The common 55, 50, and 43 kDa bands from Western blot, along with the 
similar amino acid sequence at the C-terminal end (antibody target) in 
mouse AQP4 and treefrog AQP4 homolog (HC-4), suggest that the 
commercially available anti-AQP4 polyclonal antibody also targets the 
AQP4 homolog in our frog model. 
 AQP4 proteins were expressed in all frog brain tissues in a pattern of 
three bands at 55, 50, and 38 KDa (Fig 11). These bands were not visualized 
when the blot was probed with an antibody neutralized with AQP4 peptide. 
Treating protein extracts with N-glycosidase prior to Western blotting did 
not result in any changes to the immunoblot pattern, suggesting that the three 
bands were not representing glycosylated protein (Fig 12). AQP4 expression 
did not show any statistical differences between conditions (p = 0.18). 
 
3.2.3 HC-9 expression 
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 HC-9 proteins were expressed in all brain tissues in a pattern of five 
bands at approximately 95, 43, 34, 31, and 26 KDa. These bands 
disappeared when the blot was probed with an antibody neutralized with 
HC-9 peptide (Fig 13). The 34kDa band mostly disappeared, along with 
increase in the 31 kDa band, following treatment of protein extract with N-
glycosidase, suggesting the presence of glycosylated protein (Fig14). HC-9 
expression was statistically different between cold and thawed conditions (p 
= 0.03). 
 
3.3 Localization of AQP1, 4, and 9 proteins in brain cells. 
 In each physiological condition, AQP1, 4, and 9 proteins were 
localized in brain coronal sections taken from different regions (anterior, 
mid-, and posterior) close to the ventricles (lateral, third, and optic 
ventricles, respectively). (Fig 5) 
 
3.3.1 HC-1 localizations in brain cells 
 HC-1 was found in ependymal cells surrounding ventricles, 
astrocytes, neurons, endothelia cells forming blood vessels and pia mater 
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cells. HC-1 localization did not show any apparent changes between warm, 
cold, frozen, and thawed animals. However, the intensity of the fluorescence 
signal in the cell membrane differed between conditions. The intensity of the 
signal was strongest in cold animals (Table1, 2, and 7). 
Anterior Brain, Lateral Ventricles (LV) 
 HC-1 localized strongly to the apical surface of the ependymal cells 
surrounding the LV. Cold animals showed the highest intensity of HC-1 in 
cell membranes compared to the warm condition. HC-1 was expressed in 
endothelial cells of the blood vessels. The protein signal intensity in 
endothelial cell membranes was stable through different physiological 
conditions (Fig15). The areas close to Nucleus Accumbens (NA) and 
Medium Septum (MS) specifically showed HC-1 localization to astrocytes 
and neurons (data not shown). The intensity of the HC-1 protein in these cell 
membranes was stronger in cold and frozen animals compared to control. 
Beside these cell localizations, HC-1 was abundant in pia mater membrane 
cells. 
Posterior Brain, Optic Ventricles (OV) 
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 In the posterior brain, HC-1 was expressed in cell types similar to 
anterior brain regions, except that HC-1 signals in astrocytes and neurons 
were not limited to specific regions. The highest HC-1 fluorescence intensity 
was in cold animals (Fig16).  
Mid Brain, Third Ventricle (3V) 
 HC-1 protein was localized to the apical surface of the epithelial cells 
that compose the choroid plexus. For other cells, localization was consistent 
with the anterior and posterior regions. HC-1 was found in ependymal cells 
and tanycytes surrounding the 3V, endothelia of the BBB, neurons, and 
astrocytes. Cell membranes from cold animals had a strong HC-1 signal 
compared to control (data not shown) (Table7). 
 
3.3.2 AQP4 localizations in brain cells 
 AQP4 protein was localized to astrocytes that comprise the BBB, and 
neurons. The cellular localization of AQP4 did not change between cold, 
frozen, and thawed animals, but the fluorescent intensity varied, AQP4 
signal was strong in the frozen and cold brain compared to the control, but 
was weak under thawed condition (Table 3, 4, and 7). 
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Anterior Brain, Lateral Ventricles (LV) 
 AQP4 was highly prevalent in astrocytes surrounding blood vessels 
and in neurons. Neurons were the most abundant cells showed AQP4 protein 
on the membrane. The intensity of these signals was strong in frozen animals 
compared to control animals. (Fig 18).  
Posterior Brain, Optic Ventricles (OV) and Mid Brain, Third Ventricle (3V) 
 Consistent with the results from the anterior brain, the AQP4 signal 
was strong in astrocytes and neurons. However, the fluorescent intensity in 
the cell membrane was strong in cold animals compared to control animals 
(Fig 19).   
 
3.3.3 Localization of HC-9 in brain cells 
 HC-9 proteins were localized in neurons and astrocytes. The cellular 
localization of AQP9 did not change with the different physiological 
conditions, but the fluorescent intensity in the cell membrane was stronger in 
thawed animals compared to control animals (Table 5, 6, and 7). 
Anterior Brain, Lateral Ventricles (LV) 
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 HC-9 proteins were found in groups of neurons and astrocytes in 
medial septal nucleus and lateral septal nucleus in anterior brain regions. 
The thawed animals showed strong HC-9 signal on cell membrane compared 
to control (Fig 21).   
Posterior Brain, Optic Ventricles (OV) and Mid Brain, Third Ventricle (3V) 
 AQP9 was slightly detected in neurons and astrocytes in many areas 
in the mid- and posterior brain including dorsal thalamus, entopedunular 
nucleus, leminiscus, and interpeduncular nucleus. The intensity of HC-9 was 
strong in thawed animals compared to control (Fig 22).  
 
3.3.4 Double immune labeling: 
 In mammals, glial fibrillary acidic protein (GFAP) is used as a marker 
of astrocytes.  In an effort to further confirm the identity of astrocytes in frog 
brain (in addition to using cell morphology and location), we applied anti-
mouse GFAP antibody to some immunohistochemistry analyses. GFAP was 
applied along with AQP 1, 4, or 9, using dual labeling immunofluorescence.  
 GFAP appeared to be expressed not only in astrocytes in our frog 
model but also labeled ependymal cell and neurons (Fig 17 and 20).  
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Double immune-labeling HC-1 with GFAP  
 HC-1 and GFAP were co-localized on apical surface of ependymal 
cells lining on lateral ventricle, in neurons, and astrocytes (Fig 17). 
 
Double immune-labeling AQP4 with GFAP  
 AQP4 and GFAP were co-localized on apical surface of ependymal 
cells lining on lateral ventricle, in neurons, and astrocytes (Fig 20).  
 
3.3.5 Triple immune labeling: 
 We tried to co-localize all three AQPs in brain tissue using triple 
immune labeling. AQP1, 4, and 9 were co-localized in some specific 
neurons and astrocytes in medial septal nucleus and lateral septal nucleus 
from the anterior brain (Fig 23). 
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4.0 Discussion: 
 Certain animals, such as frogs, are regularly exposed to cold and 
freezing temperatures as part of their normal life cycles. Interestingly, 
following being in a frozen state, these animals are able to recover rapidly. 
Many of these animals survive the stress of freezing by accumulating 
glucose or glycerol as a cryoprotectent and/or redistributing body fluids in 
order to reduce the risk of damage associated with freezing.  
 Freezing would be a challenge for fluid regulation in the brain. The 
extracellular liquid and cerebrospinal fluid (CSF) are likely to freeze due to 
their water content, and for those animals that accumulate glucose as a 
cryoprotectent, the blood-brain barrier (BBB) could be compromised by the 
high levels of glucose that are meant to protect during freezing. The 
challenges presented with freezing could result in cell damage, BBB 
dysfunction, and edema. AQPs may be important in the physiological 
response to those challenges and their expression may be altered in response 
to cold acclimation and freezing.  
4.1 The Blood-Brain Barrier 
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 Brain injury, infection, and hyperglycemia can all disrupt BBB 
function (the review of Lossinsky and Shivers, 2004). Brain disorders that 
result from traumatic brain injury (TBI), ischemia, or hemorrhage have been 
shown to impact the integrity of the BBB. In a study evaluating the link 
between early stage of TBI, AQP4 expression, and the BBB in rat brains, 
Hong et al., (2013) reported that the BBB was damaged on a structural level 
presenting as swelling of the endothelium, basilar membrane, and astrocyte 
processes. Moreover, numerous ischemia studies with rats and mice showed 
that the BBB was disrupted and its permeability increased following 
ischemia (Belayer et al., 1996, Kim et al., 2010, and Hong et al., 2013). 
Brain hemorrhage in mice, either intracranial hemorrhage or subarachnoid 
hemorrhage, led to inflammation and BBB disruption and these effects were 
reduced or inhibited after treatment with the steroid, methylprednisolone 
sodium succinate (MPSS) or propofol (Cheng et al., 2016 and Shi et al., 
2015). 
 Chronic hyperglycemia has also been shown to alter and disrupt the 
BBB in a mouse model of diabetes. The high oxidative metabolism of 
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glucose in these animals eventually led to BBB dysfunction (Salameh et al., 
2016, and Zhang et al., 2016).  
 The present study used the Evans Blue assay to evaluate the integrity 
of the BBB in the frog species, Hyla chrysoscelis following exposure to 
cold, freezing temperatures and upon recovery from freezing (i.e., upon 
thawing). The results described here did not show any evidence of the Evans 
Blue dye in the brain of the animals with any temperature condition. 
Compared to warm animals (control), the brains from cold, frozen, and 
thawed animals displayed in regular frog brain color (white) after dissection 
with no evidence of Evans Blue in any areas of the brain. At face value, 
these data indicate that there is no disruption to the BBB, as it was able to 
exclude the dye from entering the brain.  
 These results on the BBB integrity in Hyla chrysoscelis under low 
temperature conditions were unexpected. We expected the BBB to be 
altered, either structurally or functionally. We expected this alteration due to 
three reasons: 1.)  Frog blood during cold and frozen conditions is known to 
contain relatively high concentrations of glycerol and glucose (Croes and 
Thomas 2000; Irwin and Lee 2003; and Zimmerman et al., 2007), 2.) The 
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cells of the BBB are likely under significant physiological stress with regard 
to osmotic pressure from pure freezing and creating concentration gradients 
of solutes externally, and/or 3.) The direct physical damage from ice formed 
inside blood vessels. There are two possible explanations for the negative 
results.  First, these results may be accurate and there is no damage to the 
BBB, suggesting that these animals have a specific mechanism to resist the 
challenges of liquid freezing and glucose accumulation and protect the BBB 
in some way. Alternatively, it may be that the Evans Blue assay did not 
work well in our model, as this assay is typically performed in mammalian 
models and has not been used in frogs previously. To better determine the 
latter, it would be critical to have a positive control that induces BBB 
disruption in order to examine the applicability of the Evans Blue assay in an 
amphibian model.  
4.2 Aquaporin expression 
 Aquaporins (AQPs) 1, 3, 4, 5, 6, 8, 9, and 12 have been identified in 
both rodent and primate brains (Buffoli, 2010, Badaut et al., 2014). These 
AQPs have been localized to different cells in the CNS in normal and 
pathological conditions, such as AQP1 in choroid cells, AQP1, 3, 4, 5, 8, 
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and 9 in astrocytes, AQP8 in oligodendrocytes, AQP1, 5, and 8 in neurons, 
AQP9 in tanycytes, and AQP1, 4, and 9 in ependymal cells (Buffoli, 2010). 
Pervious brain studies reported that the expression of AQP 1, 4, and 9 was 
altered under pathological brain conditions including brain injury/trauma, 
ischemia, edema, inflammation, and hemorrhage. 
 In the normal rodent brain, AQP1 is reported to only be expressed in 
the epithelial cells of the choroid plexus and has been shown to play a role in 
CSF formation (Buffoli, 2010; Kim et al., 2010; McCoy & Sontheimer 
2010; Lee et al., 2013; and Qui et al., 2014, Potokar et al., 2016). Moreover, 
in the normal non-human primate brain, AQP1 was additionally identified in 
the astrocytes end feet surrounding blood vessels and in neurons supplying 
the pia mater (Arcienega et al., 2010). Significantly, AQP1 was not found in 
endothelial cells of blood vessels in the normal brain (Buffoli, 2010; Potokar 
et al., 2016).  
   Contrary to these published reports on AQP1, my study found that 
AQP1 was present in the warm animal brain (control) in ependymal cells 
surrounding ventricles, astrocytes, neurons, endothelia cells forming blood 
vessels and pia mater cells. AQP1 was expressed in these same cells in cold, 
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frozen and thawed animals. However, when visually comparing to the 
control, the intensity of fluorescence signals for AQP1 on the plasma 
membrane appeared significantly stronger in the cold conditions. However, 
Western blot analyses for AQP1 protein expression did not showed any 
statistical difference in AQP1 levels between cold, frozen, and thawed 
animals when compared to warm (control) animals. 
 AQP1 has been reported in endothelial cells or astrocytes in the brain 
under pathological condition such as brain injury, ischemia, subarachnoid 
hemorrhage, or brain tumors (Kim et al., 2010; Qiu et al., 2014). In fact, in 
mammals AQP1 localization in endothelial cell was dependent on the 
presence of astrocytes close to blood vessels, where AQP1 was only present 
in endothelial cells when the blood vessels were not surrounded by 
astrocytes, such as in in vitro cultures or brain tumors (Buffoli, 2010). AQP1 
expression increased after ischemia and likely works in combination with 
AQP4 in causing edema (Lee et al.,2013; Mohammadi & Dehghani 2015; 
Kim et al., 2010; Qiu et al., 2014). AQP1 levels were also increased in 
choroid plexus tumors (Buffoli, 2010). AQP1 was also detected in 
ependymal cells, neurons, astrocytes, and sensory fibers in the spinal cord 
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injury (Buffoli, 2010). Taken together, AQP1 in mammals seems to 
contribute to pathological brain conditions, such as edema, overproduction 
of CSF, and neuronal swelling (Buffoli, 2010; Lee et al.,2013; Mohammadi 
& Dehghani 2015; Kim et al., 2010; Qiu et al., 2014). While these published 
reports suggest that AQP1 is primarily linked to pathologic states, in our 
frog model, AQP1 appears to function more as house-keeping protein that is 
not altered or activated with cold and/or frozen temperatures.  
 AQP4 is the most abundant AQP in brain tissue. In the normal rodent 
brain, AQP4 is usually present in glial cells including ependymal cells and 
astrocyte end feet close to blood vessels. AQP4 plays a significant role in 
water homeostasis in brain tissues and likely plays other roles in the brain 
due to astrocyte AQP4 distributes differ in many areas of the brain (Sun et 
al., 2003; Badaut et al., 2014; Yang et al., 2015). AQP4 is not expressed in 
neurons and endothelial in normal mammalian brain (Sun et al., 2003; Blixt 
et al., 2015).  
 In contrast, our study found that AQP4 was present in neurons, and 
astrocytes close to the BBB. The localization of AQP4 was not altered in 
cold, frozen, or thawed animals compared to the control. The intensity of 
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fluorescence in cell membrane varied between conditions and areas from the 
brain. AQP4 signal was strong in the anterior brain in frozen animals while 
it was strong in cold animals in the mid- and posterior brain regions 
compared to control animals. Western blot analyses did not reveal any 
statistically significant differences between conditions.   
 In mammalian acute brain injuries including ischemia, trauma, and 
subarachnoid hemorrhage, AQP4 expression was changed in astrocytes 
(Badaut et al., 2014). Previous studies demonstrated that AQP4 contributes 
to edema formation in many pathological conditions, including ischemia, 
and trauma, such that the diminished level of AQP4 or AQP9 might help to 
minimize edema after these injuries (Yang et al., 2015). The type of brain 
injury and the time after injury determines the manner of AQP4 regulation in 
brain pathology. For example, AQP4 was up-regulated in transient brain 
ischemia around the infarct area in mice (Badaut et al., 2001). By contrast, 
AQP4 was down-regulated in early stage TBI, likely to protect cells from 
cytotoxic edema, and then up-regulated at a later stage to help in the 
clearance in vasogenic edema (Blixt et al., 2015). Moreover, Sun et al, 
(2003) reported the regulation of AQP4 in a rat TBI model where AQP4 
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increased in the trauma area and decreased in the area close to trauma, with 
no change in areas distant from trauma. The authors demonstrated that an 
increase in AQP4 in astrocyte end-feet in areas damaged by trauma may 
help to protect neurons from osmotic stress that may occur by transporting 
water from the extracellular space into the astrocytes, causing swelling. 
Using the same logic, decreasing AQP4 in areas near the site of damage 
could serve to prevent the edema from spreading to other areas.  Liang et al., 
(2015) reported that the deletion of AQP4 might be helpful in some diseases, 
such as cytotoxic cerebral edema, water intoxication, focal cerebral 
ischemia, and bacterial meningitis, while it could be harmful in other 
diseases such as in cortical freeze injury, brain tumor, and hydrocephalus. 
The authors stated that the AQP4 deletion was beneficial in the acute stage 
of micro-TBI in reducing cell death, decreasing edema and decreasing BBB 
disruption. As described above, AQP4 regulation in mammals is altered 
under pathological brain conditions. The regulation of AQP4 in mammalian 
brains under pathological conditions varies depending on the type of injury 
and the time after injury. Therefore, it is difficult to determine if AQP4 
contributes to or attenuates the effect of injury. 
 52 
Based on the findings in mammals, we had predicted that AQP4 
expression would increase in the brains of treefrogs subjected to freezing 
and thawing. This increase would help to facilitate water movement to the 
outside of cells during freezing, and protect from ice forming inside of cells.  
However, this hypothesis was only partially supported by our results.  We 
found that changing temperature conditions resulted in no significant 
difference in AQP4 protein expression in the whole brain. However, 
immunofluorescence labeling showed differences in signal intensity between 
conditions and regions of brain. The signal of AQP4 in anterior was strong 
in frozen animals while the signal of AQP4 in mid-and posterior brain was 
strong in cold animals. Unfortunately, immunofluorescence is difficult to be 
a reliably quantify the change in AQP4 signal intensity between conditions 
and from region to another. Notwithstanding, AQP4 might be significant in 
water transport during cold, freezing, and thawing to help cells to survive. 
Moreover, finding AQP4 in neurons in our frog might be significant 
especially considering that neurons in the frog are not protected like those in 
mammals. Neurons in the frog during cold, frozen, and thawed conditions 
would be expected to face many stresses such cell hydration, and different 
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osmotic pressure that require mechanisms to control water transport to and 
from cells. 
 Previous studies reported that AQP9 in the normal rodent brain was 
expressed in three types of cells: Glial cells, endothelial cells, and neurons. 
The expression of AQP9 in glial cells was detected in the cell body and 
processes of astrocytes and in tanycytes. Further, AQP9 expression was 
limited only to pial vessel endothelial cells and was not found in vessels 
supplying the brain parenchyma. Glia and endothelial localization for AQP9 
form the basis for its important role in water homeostasis between the BBB 
and CSF. AQP9 was also localized to specific types of neurons known as 
catecholaminergic cells and AQP9 has been suggested to play a significant 
role in neuron energy by transporting organic molecules such as lactate, and 
glycerol (Badaut et al., 2004; Liu et al., 2014; Badaut et al., 2014).  
  In our present research, AQP9 expression was localized to astrocytes 
and specific neurons in control (warm) animals. These neurons were 
specifically found in medial septial nucleus and lateral septial nucleus in the 
anterior brain. Additionally, AQP9 was minimally detected in neurons and 
astrocytes in many areas in the mid- and posterior brain including dorsal 
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thalamus, entopedunular nucleus, leminiscus, and interpeduncular nucleus. 
Although cold, frozen and thawed animals did not show any changes in 
AQP9 cellular localization, thawed animals displayed strong fluorescence 
intensity compared to control animals. Western blot analyses confirmed the 
immunofluorescent staining results and showed a statistical difference 
between cold and thawed animals. High expression of AQP9 was detected in 
thawed animals compared to cold animals.  
 Studies in rodents have reported that AQP9 regulation was altered 
under different pathological conditions such as acute injuries, ischemia, 
trauma, and hemorrhage (Badaut et al., 2004; Liu et al., 2001; Wang et al., 
2015). AQP9 expression was up-regulated in brain ischemia and this 
increase highlights the roles of AQP9 in edema formation and lactate 
clearance in the extracellular space (Badaut et al., 2004). Liu et al., (2011) 
stated that AQP9 was up-regulated in both early and later stages of TBI. The 
authors pointed out the significant roles of AQP9 in edema, lactate, and 
glycerol clearance at an early stage and neuronal repair and cellular edema 
formation at a later stage. AQP1, 4, and 9 were increased after intracerebral 
hemorrhage (ICH) and only AQP4, and 9 were attenuated by curcumin after 
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ICH (Wang et al., 2015). The uncorrelated results between AQP9 expression 
after ischemic injures and the edema volume suggested that AQP9 did not 
contribute in edema after ischemia (Wang et al., 2015). To summarize, 
AQP9 was up-regulated in rodent brain disorders and this up-regulation 
correlated to clearance of excessive water, lactate, and glycerol that usually 
accumulate after brain disorders and also involved in neuron metabolism and 
energy by delivering glycerol and lactate.  
 In our present study, the up-regulation of AQP9 in thawed animals 
may relate to the significant role of AQP9 in clearance glycerol that 
accumulates in cold stage in order to prepare animals for freezing. At the 
same tim e, AQP9-mediated glycerol uptake into neural tissues might be 
important in delivering glycerol for neuron metabolism and energy upon 
thawing.  
 
5.0 Conclusions 
 The overall results of this study suggest that freezing did not damage 
the BBB in the freeze-tolerant gray treefrog.  Aquaporins 1, 4, and 9 were 
expressed in many cell types within the brain and are likely to contribute to 
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cell volume regulation when extracellular ice forms in the brain.  Expression 
of AQPs in the brain varied somewhat with condition. These results only 
partly support our hypotheses. Additional experiments should be performed 
in order to more fully test the hypotheses.  
 One weakness of this study is that there was no positive control to 
demonstrate the effectiveness of the Evans Blue assay in an amphibian 
model. Positive control animals that provide BBB disruption by factors such 
as hyperglycemia or cold lesion injury might be appropriate with the frog 
model. However, finding the proper concentration of glucose in blood to 
alter BBB would be challenging, especially given that gray treefrogs use 
glucose as freezing cryoprotective chemical. Moreover, cold lesion injury 
might be difficult with our model due to the small size of brain. Regardless, 
developing a positive control for use with this assay in the frog model would 
serve to validate negative results. Additionally, the distribution of the Evans 
Blue tracer into the brain is assessed on a gross level with the naked eye. 
This may not be a sensitive enough measure for this animal model and 
microscopy may be more appropriate to assess subtle differences.  Light 
microscopy may not be sensitive enough, thus requiring higher 
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magnification power like electron microscopy with proper tracers like 
horseradish peroxidase (HRP). Electron microscopy may also be able to 
detect physical changes in the BBB. 
 Additionally, it is important to investigate AQP 1, 4, and 9 on both the 
mRNA and protein level in each region of the brain to sensitively identify 
the exact expression of the various AQPs. This is challenging because the 
brains of these animals are small and so it may be difficult to collect enough 
protein from the various regions of the brain. 
 Investigating other AQPs such as 3, 5, 6, 8, and 12 in frog brain tissue 
on the protein and mRNA levels might be significant in water transport 
during freezing. Also, using more specific antibody markers and histology 
staining for brain tissues might be more precise to identify cell types.  
 Adjustments in the intervals at which these endpoints are assessed 
may also be useful. It may be that the frogs recover quickly and any 
alterations are missed. Additional or earlier time points may more telling 
with regard to disruptions/repair.  
 Cryogenic lesion studies showed BBB leaking in mice brain, whereas 
in our frog model Hyla chrysoscelis BBB was protected in some way from 
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cold and freezing temperatures. For that reason, investigating the mechanism 
of how these frog protect their BBB from cold and freezing temperatures 
could have significant implications for medical control of BBB disruptions 
resulting from brain injuries and diseases, or perhaps for regulation of BBB 
permeability that could allow treatments to enter brain tissues.  Likewise, 
disrupted fluid regulation in the brain is a critical component of many brain 
injuries. Our findings that AQP expression is altered in specific conditions 
and cell types could have implications for therapeutic approaches to edema 
and other brain pathologies. 
 Finally, Gray treefrogs recover mobility and behavior quickly after 
they thaw.  This impressive recovery indicates that the brain is well 
protected from damage during freezing. We have made first steps to identify 
the mechanisms that provide that protection.  
 
 59 
 
 
 
 
Fig 8: Evans blue experiment to assesse BBB integrity under different 
physiological conditions. Warm animals (control) showed negative 
EB in brain. In Cold, frozen, and thawed animals, brain tissues were 
normal white grayish in color, comparable to control, and EB was not 
detected in any areas of the brain.  
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Fig 9: Western blots presenting HC-1 protein expression in whole brain 
from different physiological conditions. A1&2) HC-1 was expressed in 
double bands, a band at 43 kDa and a band at 28 kDa in warm, cold, frozen, 
and thawed conditions. B1&2) HC-1 antibody was pre-incubated with its 
antigenic peptide. C) Expression of HC-1 was quantified in reference to 
actin of frog (n=4).  The p-value is 0.78 for ANOVA test at F (3,11)= 
0.3651. There are no statistically significant differences for HC-1 protein 
between conditions. The error bars represent standard deviation (SD). 
9 C 
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Fig 10: Test for glycosylation of HC-1.  Proteins were treated with N-
glycosidase before loaded in 12% SDS-PAGE. A1, 2, 3, and 4) The 43 kDa 
bands disappeared with the enzyme treatment while the 28 kDa bands 
appeared with the enzyme in stronger intensity in all (warm, cold, frozen, 
and thawed) conditions. B1, 2, 3, and 4) HC-1 antibody was pre-incubated 
with its antigenic peptide. C) Expression of 28 kDa and 43 kDa bands of 
HC-1 protein, with (w) and without (wo) glycosidase enzyme treatment, was 
quantified in reference to actin of frog (n=4).  The p-value is 0.47 for 
ANOVA test at F (3, 44) = 0.8519. There are no statistically significant 
differences for HC-1 protein (Glycosylated, and Deglycosylated) between 
conditions. The error bars represent standard deviation (SD). 
10 C 
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Fig 11: Western blots presenting AQP4 protein expression in whole brain 
from different physiological conditions. A) AQP4 was expressed in three 
bands at 38, 50, and 55 kDa in warm, cold, frozen, and thawed conditions. 
B) AQP4 antibody was pre-incubated with its antigenic peptide. C) 
Expression of AQP4 was quantified in reference to actin of frog (n=4).  The 
p-value is 0.18 for ANOVA test at F (3, 11) = 1.977. There are no 
statistically significant differences for AQP4 protein between conditions. 
The error bars represent standard deviation (SD). 
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Fig 12: Test for glycosylation of AQP4. Proteins were treated with N-
glycosidase before loaded in 12% SDS-PAGE. A1, 2, 3, 4) The three bands 
at 38, 50, 55 kDa with the enzyme treating and without the enzyme appeared 
in the similar intensity without any changes in all (warm, cold, frozen, and 
thawed) conditions. B) Expression of 38, 50, and 55 kDa bands of AQP4 
protein, with (w) and without (wo) glycosidase enzyme treatment, was 
quantified in reference to actin of frog (n=4). There are no statistically 
significant differences for AQP4 protein between conditions. The error bars 
represent standard deviation (SD). 
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Fig 13: Western blots presenting HC-9 protein expression in whole brain 
from different physiological conditions. A1&2) HC-9 was expressed in five 
bands 95, 43, 34, 31, 26 kDa in all (warm, cold, frozen, and thawed) 
conditions. B1&2) HC-9 antibody was pre-incubated with its antigenic 
peptide. C) Expression of HC-9 was quantified in reference to actin of frog 
(n=4). The p-value is 0.03 for ANOVA test at F (3, 11) = 4.231. There are 
significant statistical differences for HC-9 protein between cold and thawed 
conditions (*). The error bars represent standard deviation (SD). 
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Fig 14: Test for glycosylation of HC-9. Proteins were treated with N-
glycosidase before loaded in 12% SDS-PAGE. A1, 2, 3, 4) The 34kDa 
disappeared with the enzyme treatment and the 31 kDa with the enzyme 
appeared stronger intensity. The others bands appeared in slimier intensity 
with and without enzyme treatment without any changes in all (warm, cold, 
frozen, and thawed) conditions. B1, 2, 3, 4) HC-9 antibody was pre-
incubated with its antigenic peptide. C) Expression of 95, 43, 34, 31 and 26 
14 C 
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kDa bands of AQP4 protein, with (w) and without (wo) glycosidase enzyme 
treatment, was quantified in reference to actin of frog (n=4). The p-value is 
0.0001 for ANOVA test at F (3, 44) = 11.50. There is significant statistically 
differences for HC-9 protein between cold and thawed (*), warm and thawed 
(#), and Frozen and thawed conditions (^).The error bars represent standard 
deviation (SD). 
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15 I) HC-1 localized in endothelial cells and ependymal cells in anterior 
brain close to LV  
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15 II) HC-1 localized in endothelial cells and ependymal cells in anterior 
brain close to LV  
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Fig 15: HC-1 localization in endothelial cells and ependymal cells in anterior 
brain close to LV. Confocal images presenting co-localization of HC-1 
proteins in lateral ventricles (LV) region from anterior brain tissue of Gray 
tree frog, Hyla chrysoscelis, under different physiological conditions. I) (a) 
HC-1 was localized using rabbit anti-HC-1 primary antibody and Cy2 
labeled goat anti-rabbit secondary antibody (Green). (b) Merge image (HC-
1/ Nuclei) the cell nuclei were counterstained using DAPI (Blue). (c) No 
signal was detected in any part of front brain tissue when anti-HC-1 pre-
absorbed with corresponding antigen peptide. II) Images showing HC-1 
signals on: apical surface of ependymal cells lining on lateral ventricle 
(arrowhead), endothelial cell of blood vessels (arrow). Scale=50u, (*) is 
blood vessels. Frog numbers (n=3). 
Anterior brain/HC-1 Warm Cold Frozen Thawed 
Ependymal cells  +++ ++++ +++ +++ 
Endothelial cells ++++ ++++ ++++ ++++ 
Astrocytes close to BBB +  + + +  
Neurons + + + + 
 
Table 1: Summary of the cellular localization of HC-1 in anterior brain from 
different physiological conditions and illustrates the fluorescence signal 
intensity differences between conditions. 
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16 I) HC-1 localized in endothelial cells, ependymal cells, neurons, and 
astrocytes in posterior brain close to AQ 
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16 II) HC-1 localized in endothelial cells, ependymal cells, neurons, and 
astrocytes in posterior brain close to OV 
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Fig 16: HC-1 localization in endothelial cells, ependymal cells, neurons, and 
astrocytes in posterior brain. Confocal images presenting co-localization of 
HC-1 proteins in I) Aqueduct (AQ) and II) optic ventricles (OV) regions 
from posterior brain tissue of Gray tree frog, Hyla chrysoscelis, under 
different physiological conditions. (a) HC-1 was localized using rabbit anti-
HC-1 primary antibody and Cy2 labeled goat anti-rabbit secondary antibody 
(Green). (b) Merge image (HC-1/ Nuclei) the cell nuclei were counterstained 
using DAPI (Blue).  No signal was detected in any part of front brain tissue 
when anti-HC-1 pre-absorbed with corresponding antigen peptide. HC-1 
signals were found on: apical surface of ependymal cells lining on lateral 
ventricle (arrow head), endothelial cell of blood vessels (arrow), astrocytes 
in contact with BBB (blocked arrow), neurons (dotted arrow). Scale=50u, 
(*) is blood vessels. Frog numbers (n=3). 
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Posterior brain/HC-1 Warm Cold Frozen Thawed 
Ependymal cells  +++ ++++ +++ ++ 
Endothelial cells of BBB +++ ++++ +++ ++ 
Astrocytes close to BBB +++ ++++ +++ ++ 
Neurons + +++ + + 
 
Table 2: Summary of the cellular localization of HC-1 in posterior brain 
from different physiological conditions and illustrates the fluorescence 
signal intensity differences between conditions. 
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17 I) Warm brain: 
 
17 II) Cold brain: 
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17 III) Frozen brain: 
 
17 IV) Thawed brain: 
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Fig 17: Co-localization of HC-1 with glial fibrillary acidic protein (GFAP) 
on ependymal cells, neurons, and astrocytes. Confocal images presenting 
double immune-labeling HC-1 with glial fibrillary acidic protein (GFAP) in 
area close to lateral ventricles (LV) from anterior brain of Gray tree frog, 
Hyla chrysoscelis, under different physiological conditions (I warm, II cold, 
III frozen, IV thawed). (a) HC-1 was localized using rabbit anti-HC-1 
primary antibody and Cy2 labeled goat anti-rabbit secondary antibody 
(Green). (b) GFAP was localized using rabbit anti-GFAP primary antibody 
and Cy3 labeled goat anti-rabbit secondary antibody (read). (e) Cell nuclei 
were counterstained using DAPI (Blue). (d) HC-1 and GFAP were co-
localized in the same areas (yellow): on apical surface of ependymal cells 
lining on lateral ventricle (arrowhead), and in neurons (arrow), astrocytes 
(blocked arrow). (e) Merge image (HC-1, GFAP, and nuclei). Scale=50u, (*) 
is blood vessels. Frog numbers (n=3). 
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18 I) AQP4 localized in neurons and astrocytes in anterior brain close to LV 
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18 II) AQP4 localized in neurons and astrocytes in anterior brain close to LV 
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Fig 18: AQP4 localization in neurons and astrocytes in anterior brain close 
to LV. Confocal images presenting co-localization of AQP4 proteins in 
lateral ventricles (LV) region from anterior brain tissue of Gray tree frog, 
Hyla chrysoscelis, under different physiological conditions. I) 20x 
magnification (a) AQP4 was localized using rabbit anti-AQP4 primary 
antibody and Cy2 labeled goat anti-rabbit secondary antibody (Green). (b) 
Merge image (AQP4/ Nuclei) the cell nuclei were counterstained using 
DAPI (Blue). (c) No signal was detected in any part of front brain tissue 
when anti-AQP4 pre-absorbed with corresponding antigen peptide. II) 
AQP4 signals on apical surface of ependymal cells lining on lateral ventricle 
(arrow head), neurons (arrow), astrocytes (blocked arrow). Scale=50u, (*) is 
blood vessels. Frog numbers (n=3). 
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Anterior brain/AQP4 Warm Cold Frozen Thawed 
Ependymal cells  - - - - 
Endothelial cells of BBB - - - - 
Astrocytes close to BBB ++++ ++ ++++ +++ 
Neurons +++ ++ ++++ +++ 
 
Table 3: Summary of the cellular localization of AQP4 in anterior brain 
from different physiological conditions and illustrates the fluorescence 
signal intensity differences between conditions. 
 
 
 
 
 
 
 
 
 
 
 96 
19 I) AQP4 localized in neurons and astrocytes in posterior brain close to 
AQ 
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19 II) AQP4 localized in neurons and astrocytes in posterior brain close to 
OV 
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Fig 19: AQP4 localization in neurons and astrocytes in posterior brain. 
Confocal images of presenting co-localization of AQP4 proteins in I) 
Aqueduct (AQ) and II) optic ventricles (OV) regions from posterior brain 
tissue of Gray tree frog, Hyla chrysoscelis, under different physiological 
conditions. (a) AQP4 was localized using rabbit anti-AQP4 primary 
antibody and Cy2 labeled goat anti-rabbit secondary antibody (Green). (b) 
Merge image (AQP4/ Nuclei) the cell nuclei were counterstained using 
DAPI (Blue).  No signal was detected in any part of front brain tissue when 
anti-AQP4 pre-absorbed with corresponding antigen peptide. AQP4 signals 
were found on: neurons (arrow), astrocytes in contact with BBB (blocked 
arrow). Scale=50u, (*) is blood vessels. Frog numbers (n=3). 
Posterior brain/AQP4 Warm Cold Frozen Thawed 
Ependymal cells  - - - - 
Endothelial cells of BBB - - - - 
Astrocytes close to BBB +++ ++++ +++ ++ 
Neurons +++ ++++ +++ ++ 
 
Table 4: Summary of the cellular localization of AQP4 in posterior brain 
from different physiological conditions and illustrates the fluorescence 
signal intensity differences between conditions. 
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20 I) Warm brain:  
 
20 II) Cold brain: 
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20 III) Frozen brain: 
 
20 IV) Thawed brain: 
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Fig 20: Co-localization of AQP4 with glial fibrillary acidic protein 
(GFAP) on neurons, and astrocytes. Confocal images presenting double 
immune-labeling AQP4 with glial fibrillary acidic protein (GFAP) in 
area close to lateral ventricles (LV) from anterior brain of Gray tree frog, 
Hyla chrysoscelis, under different physiological conditions (I warm, II 
cold, III frozen, IV thawed). (a) AQP4 was localized using rabbit anti-
AQP4 primary antibody and Cy2 labeled goat anti-rabbit secondary 
antibody (Green). (b) GFAP was localized using rabbit anti-GFAP 
primary antibody and Cy3 labeled goat anti-rabbit secondary antibody 
(read). (e) Cell nuclei were counterstained using DAPI (Blue). (d) AQP4 
and GFAP were co-localized in the same areas (yellow): in neurons 
(arrow), astrocytes (blocked arrow). (e) Merge image (AQP4, GFAP, and 
nuclei). Scale=50u, (*) is blood vessels. Frog numbers (n=3). 
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21 I) HC-9 localized in neurons and astrocytes in anterior brain clos to LV  
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21 II) HC-9 localized in neurons and astrocytes in anterior brain clos to LV 
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Fig 21: HC-9 localization in neurons and astrocytes in anterior brain clos to 
LV. Confocal images presenting co-localization of HC-9 proteins in lateral 
ventricles (LV) region from anterior brain tissue of Gray tree frog, Hyla 
chrysoscelis, under different physiological conditions. I) (a) HC-1 was 
localized using rabbit anti-HC-9 primary antibody and Cy2 labeled goat 
anti-rabbit secondary antibody (Green). (b) Merge image (HC-9/ Nuclei) the 
cell nuclei were counterstained using DAPI (Blue). (c) No signal was 
detected in any part of front brain tissue when anti-HC-9 pre-absorbed with 
corresponding antigen peptide. II) HC-9 signals on: specific groups of 
neurons (arrow), and astrocytes (blocked arrow). Scale=50u, (*) is blood 
vessels. Frog numbers (n=3). 
Anterior brain/HC-9 Warm Cold Frozen Thawed 
Ependymal cells  - - - - 
Endothelial cells of BBB - - - - 
Astrocytes close to BBB +++ + ++ ++++ 
Neurons in NA +++ + ++ ++++ 
 
Table 5 Summary of the cellular localization of HC-9 in anterior brain from 
different physiological conditions and illustrates the fluorescence signal 
intensity differences between conditions. 
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22 I) HC-9 localized in neurons and astrocytes in posterior brain close to AQ 
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Fig22: HC-9 localization in neurons and astrocytes in posterior brain close to 
AQ. Confocal images presenting co-localization of HC-9 proteins in I) 
Aqueduct (AQ) regions from posterior brain tissue of Gray tree frog, Hyla 
chrysoscelis, under different physiological conditions. (a) HC-9 was 
localized using rabbit anti-HC-9 primary antibody and Cy2 labeled goat 
anti-rabbit secondary antibody (Green). (b) Merge image (HC-9/ Nuclei) the 
cell nuclei were counterstained using DAPI (Blue).  No signal was detected 
in any part of front brain tissue when anti-HC-9 pre-absorbed with 
corresponding antigen peptide. HC-9 signals were found on: astrocytes in 
contact with BBB (blocked arrow), neurons (dotted arrow). Scale=50u, (*) is 
blood vessels. Frog numbers (n=3). 
Posterior brain/HC-9 Warm Cold Frozen Thawed 
Ependymal cells  - - - - 
Endothelial cells of BBB - - - - 
Astrocytes close to BBB + ++  + +++ 
Neurons + ++ + +++ 
 
Table 6: Summary of the cellular localization of HC-9 in posterior brain 
from different physiological conditions and illustrates the fluorescence 
signal intensity differences between conditions. 
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Mid brain/AQP4 Warm Cold Frozen Thawed 
Ependymal cells 
line the ventricles 
- - - - 
Endothelial cells of 
BBB 
- - - - 
Astrocytes close to 
BBB 
++ +++ +++ + 
Neurons ++ +++ +++ + 
 
Mid brain/HC-1 Warm Cold Frozen Thawed 
Ependymal cells 
line the ventricles 
+++ +++ + ++ 
Endothelial cells of 
BBB 
+++ +++ +++ + 
Astrocytes close to 
BBB 
++ ++ + + 
Neurons ++ ++ + + 
 
Mid brain/HC-9 Warm Cold Frozen Thawed 
Ependymal cells 
line the ventricles 
- - - - 
Endothelial cells of 
BBB 
- - - - 
Astrocytes close to 
BBB 
+ + + ++ 
Neurons + + + ++ 
 
 
Table7: Summary of the cellular localization of HC-1, AQP4, and HC-9 
in mid brain from different physiological conditions and illustrate the 
fluorescence signal intensity differences between conditions. 
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23)  
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Fig23: Co localization of HC-1, AQP4, and HC-9 in neurons and 
astrocytes. Confocal images presenting triple immune-labeling HC-1, 
AQP4, and HC-9 in area close to lateral ventricles (LV) from anterior 
brain of Gray tree frog, Hyla chrysoscelis, under frozen condition (a) 
Merge image presenting the triple staining for HC-1, AQP4, and HC-9 
with counterstaining DAPI for cell nuclei (Blue). (b) HC-1 was localized 
using rabbit anti-HC-1 primary antibody and Cy5 labeled goat anti-rabbit 
secondary antibody (magenta). (c) AQP4 was localized using rabbit anti-
AQP4 primary antibody and Cy2 labeled goat anti-rabbit secondary 
antibody (Green). (d) HC-9 was localized using rabbit anti-HC-9 primary 
antibody and Cy3 labeled goat anti-rabbit secondary antibody (read). (e) 
Merge image showing HC-1, AQP4, and HC-9 were co-localized in the 
same areas (arrow): neurons and astrocytes. (f) Merge image showing 
(HC-1&AQP4) were co-localized in the same areas (arrow): neurons and 
astrocytes. (g) Merge image showing (HC-1&HC-9) were co-localized in 
the same areas (arrow): neurons and astrocytes. (h) Merge image 
showing (AQP4& HC-9) were co-localized in the same areas (arrow): 
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neurons and astrocytes. Scale=20u, (*) is blood vessels. Frog numbers 
(n=3). 
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